Eisai Targeted Again Over Aciphex Patent
For the second time in less than six months, Eisai Co. Ltd. has been slapped with an antitrust lawsuit that claims the Japanese drug maker attempted to prevent a generic version...To view the full article, register now.
Already a subscriber? Click here to view full article